Pfizer (PFE) Shares Outstanding (2009 - 2026)

Pfizer (PFE) has reported Shares Outstanding (Entity) for 18 consecutive years, with $5.7 billion the latest figure, recorded in Q2 2026.

• On a quarterly basis, Shares Outstanding (Entity) changed 0.25% year-over-year to $5.7 billion in Q2 2026; TTM through Jun 2026 was $5.7 billion, a 0.25% change from a year earlier, with the FY2025 full-year figure at $5.7 billion, changed 0.33% from the prior year.
• Shares Outstanding (Entity) was $5.7 billion for Q2 2026 at Pfizer, roughly flat from $5.7 billion in the prior quarter.
• Over five years, Shares Outstanding (Entity) peaked at $5.7 billion in Q2 2026 and troughed at $5.6 billion in Q2 2022.
• A 5-year average of $5.7 billion and a median of $5.7 billion in 2024 frame the typical range for Shares Outstanding (Entity).
• Across the five-year window, Shares Outstanding (Entity) fell 0.08% in 2022 and grew 0.61% in 2023, its largest moves.
• Over 5 years, Shares Outstanding (Entity) stood at $5.6 billion in 2022, then grew by 0.49% to $5.6 billion in 2023, then advanced by 0.36% to $5.7 billion in 2024, then gained by 0.33% to $5.7 billion in 2025, then rose by 0.24% to $5.7 billion in 2026.
• The last three Shares Outstanding (Entity) figures came in at $5.7 billion (Q2 2026), $5.7 billion (Q1 2026), and $5.7 billion (Q4 2025), per Business Quant data.